<--- Back to Details
First PageDocument Content
Research / Drug safety / Pharmacology / European Medicines Agency / Pharmaceuticals policy / Committee for Medicinal Products for Human Use / International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use / Pharmacovigilance / Serious adverse event / Clinical research / Pharmaceutical sciences / Pharmaceutical industry
Date: 2014-12-17 05:29:48
Research
Drug safety
Pharmacology
European Medicines Agency
Pharmaceuticals policy
Committee for Medicinal Products for Human Use
International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use
Pharmacovigilance
Serious adverse event
Clinical research
Pharmaceutical sciences
Pharmaceutical industry

25 SeptemberEMA/CHMPCommittee for Medicinal Products for Human Use (CHMP) Assessment report

Add to Reading List

Source URL: www.ema.europa.eu

Download Document from Source Website

File Size: 2,74 MB

Share Document on Facebook

Similar Documents

Microsoft Word - SOP editedonlineversibaru.doc

Microsoft Word - SOP editedonlineversibaru.doc

DocID: 1rqX4 - View Document

Microsoft Word - Abbreviations List Approved Oct 2014

Microsoft Word - Abbreviations List Approved Oct 2014

DocID: 1qCp5 - View Document

Statement German Network for Evidence-based Medicine Berlin, 05 JulyThe German Network for Evidence-based Medicine endorses the

Statement German Network for Evidence-based Medicine Berlin, 05 JulyThe German Network for Evidence-based Medicine endorses the

DocID: 1qiz3 - View Document

Microsoft Word - Unanticipated_Problems

Microsoft Word - Unanticipated_Problems

DocID: 1pvDq - View Document

PHARMACOVIGILANCE GUIDE FOR ADVERSE DRUG REACTION MONITORING AND CAUSALITY ASSESSMENT, 2015  Post marketing Control Division,

PHARMACOVIGILANCE GUIDE FOR ADVERSE DRUG REACTION MONITORING AND CAUSALITY ASSESSMENT, 2015 Post marketing Control Division,

DocID: 1p9e5 - View Document